Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 4/20 | 0.50 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.50 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.50 |
| ▸ | GCGR | P47871 | 1/20 | 0.50 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.50 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.50 |
| ▸ | HPGDS | O60760 | 1/20 | 0.50 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | PI4KA | P42356 | 1/20 | 0.43 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.43 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.43 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.43 |
| ▸ | NT5E | P21589 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31305520 | 1.00 | NPY5R (0.50) | NPY5RMAPK14MAPK13GCGRMAPK12 | |
| SCHEMBL5125964 | 0.89 | NPY5R (0.55) | NPY5RMAPK14MAPK13GCGRMAPK12 | |
| SCHEMBL31305448 | 0.89 | NPY5R (0.55) | NPY5RMAPK14MAPK13GCGRMAPK12 | |
| SCHEMBL2951436 | 0.83 | MAPK14 (0.69) | MAPK14MAPK13GCGRMAPK12MAPK11 | |
| SCHEMBL7141861 | 0.81 | NPY5R (0.50) | NPY5RHPGDSSMPD3MGAMPOLB | |
| SCHEMBL27741799 | 0.81 | MAPK14 (0.56) | MAPK14MAPK13GCGRMAPK12MAPK11 | |
| SCHEMBL27741597 | 0.81 | MAPK13 (0.50) | MAPK14MAPK13GCGRMAPK12MAPK11 | |
| SCHEMBL27762191 | 0.81 | MAPK13 (0.50) | MAPK14MAPK13GCGRMAPK12MAPK11 | |
| SCHEMBL27741594 | 0.81 | MAPK14 (0.53) | MAPK14MAPK13GCGRMAPK12MAPK11 | |
| SCHEMBL27729265 | 0.80 | PI4KA (0.47) | NPY5RMAPK14MAPK13GCGRMAPK12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107971655-B | High-heat-resistance organic solder flux and application thereof | 永星化工(上海)有限公司 | 2019-12-27 | — | — | CN | claimed |
| CN-107971655-A | A kind of high heat-resistance organic solder ability preservative and its application | 永星化工(上海)有限公司 | 2018-05-01 | — | — | CN | claimed |
| EP-1753728-B1 | PHENYLNAPHTHYLIMIDAZOLES FOR USE ON COPPER SURFACES DURING SOLDERING | SHIKOKU CHEM (JP) | 2012-12-19 | — | — | EP | claimed |
| CN-101624374-B | Phenylnaphthylimidazoles for use on copper surfaces during soldering | SHIKOKU CHEM JP | 2012-03-21 | — | — | CN | claimed |
| CN-101624374-A | Phenylnaphthylimidazoles for use on copper surfaces during soldering | SHIKOKU CHEM | 2010-01-13 | — | — | CN | claimed |
| US-20250215572-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | SHIKOKU CHEMICALS CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-4506488-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | Shikoku Chemicals Corporation (JP) | 2025-02-12 | — | — | EP | disclosed |
| WO-2023190263-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | 四国化成工業株式会社 | 2023-10-05 | — | — | WO | disclosed |
| CN-107971655-B | High-heat-resistance organic solder flux and application thereof | 永星化工(上海)有限公司 | 2019-12-27 | — | — | CN | disclosed |
| CN-107971655-A | A kind of high heat-resistance organic solder ability preservative and its application | 永星化工(上海)有限公司 | 2018-05-01 | — | — | CN | disclosed |
| US-8378116-B2 | Phenylnaphthylimidazole compound and usage of the same | SHIKOKU CHEMICALS CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| US-8378116-B2 | Phenylnaphthylimidazole compound and usage of the same | SHIKOKU CHEMICALS CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| CN-101525745-A | Metal surface treatment agent and printed wiring board with protecting film formed thereby | UNIV SICHUAN | 2009-09-09 | — | — | CN | disclosed |
| CN-101448978-A | Surface treating agent for metal and use thereof | SHIKOKU CHEM (JP) | 2009-06-03 | — | — | CN | disclosed |
| US-20070246134-A1 | Phenylnaphthylimidazole Compound and Usage of the Same | SHIKOKU CHEMICALS CORPORATION (JP) | 2007-10-25 | — | — | US | disclosed |
| US-20070246134-A1 | Phenylnaphthylimidazole Compound and Usage of the Same | SHIKOKU CHEMICALS CORPORATION (JP) | 2007-10-25 | — | — | US | disclosed |
| US-20070246134-A1 | Phenylnaphthylimidazole Compound and Usage of the Same | SHIKOKU CHEMICALS CORPORATION (JP) | 2007-10-25 | — | — | US | disclosed |
| CN-1964949-A | Phenylnaphthylimidazoles for use on copper surfaces during soldering | SHIKOKU CHEM (JP) | 2007-05-16 | — | — | CN | disclosed |
| EP-1753728-A1 | PHENYLNAPHTHYLIMIDAZOLES FOR USE ON COPPER SURFACES DURING SOLDERING | SHIKOKU CHEMICALS CORPORATION (JP) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005121101-A1 | PHENYLNAPHTHYLIMIDAZOLES FOR USE ON COPPER SURFACES DURING SOLDERING | SHIKOKU CHEMICALS CORPORATION (JP) | 2005-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070246134-A1 | Phenylnaphthylimidazole Compound and Usage of the Same | CYP1A1, CYP1A2, P4HA1 | NPY5R 2990/4885MAPK14 1499/4885MAPK13 1493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.